Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events ari gnanasakthy represents rti hs recent pro workshop
Webinar: Strategic Planning for Orphan Drugs Share on: Tuesday, June 7, 2022, 10 - 11am Maximizing Asset Value Through Evidence Generation Planning When developing new products to treat rare diseases, it is particularly challenging to demonstrate …
… claims - Inform safety studies and reduce risks of adverse events Abandoned Drugs - Rescue, repurpose, or resurrect …
… Kingdom Verity Watson, PhD, is a Senior Economist at RTI-HS. Dr. Watson has over 25 years of experience in conducting … of patients and other healthcare decision-makers. Her most recent research has elicited preferences for prostate cancer …
… results. Q. Can you please give few tips to adapt GVD to recent EUnetHTA Core template? A. GVDs are designed as …
… PhD, FISPE, is Vice President of Epidemiology with RTI-HS and a licensed pharmacist. Dr. Gilsenan’s primary areas of … of medications, biologics, and devices. Since joining RTI in 1997, she has applied innovative approaches to the …
… version of map With offices located around the globe, RTI-HS is truly an international and diverse organization. …
… FRCP, is Vice President and Global Head of Epidemiology at RTI-HS since 2007. Dr. Perez-Gutthann holds medical and doctoral …
… eventual market access. Since the new guidance release, RTI Health Solutions (RTI-HS) has prepared numerous unapproved product dossiers …
… (RSVVW) Share on: January 9, 2023 Research coauthored by RTI Health Solutions researchers will be presented at …
… Kennedy-Martin et al. (2020) Czech Republic Státní Ústav pro Kontrolu Léčiv [State Institute for Drug Control] EQ-5D … Analysis Critical Appraisal Procedure (Státní Ústav pro Kontrolu Léčiv, 2017); Kennedy-Martin et al. (2020) …